Biotech Community Sparks: This Company Presents Promising Results

Onconova Therapeutics Presents Promising Preclinical Data for Narazaciclib at MCL Meeting.

Onconova Therapeutics Presents Promising Preclinical Data for Narazaciclib at MCL Meeting

Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company, recently presented promising preclinical data for their drug candidate, Narazaciclib, during the European MCL Network Annual Meeting. The news has sparked significant interest wi…